A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine... by Emmanuel Deshayes, Eric Assenat, Laetitia Meignant, Manuel Bardiès, Lore Santoro, Sophie Gourgou

Get full text

Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones by Laure Cayrefourcq, Frédéric Thomas, Thibault Mazard, Eric Assenat, Said Assou, Catherine Alix-Panabières

Get full text

FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis by José Ursic-Bedoya, Guillaume Desandré, Carine Chavey, Pauline Marie, Arnaud Polizzi, Benjamin Rivière, Hervé Guillou, Eric Assenat, Urszula Hibner, Damien Gregoire

Get full text

Anticancer Drugs for Intra-Arterial Treatment of Colorectal Cancer Liver Metastases: In-Vitro Screening after Short Exposure Time by Audrey Fohlen, Karim Bordji, Eric Assenat, Céline Gongora, Céline Bazille, Jérémy Boulonnais, Mikaël Naveau, Cécile Breuil, Elodie A. Pérès, Myriam Bernaudin, Boris Guiu

Get full text

Deportalization, Venous Congestion, Venous Deprivation: Serial Measurements of Volumes and Functions on Morphofunctional 99mTc-Mebrofenin SPECT-CT by Lauranne Piron, Emmanuel Deshayes, Christophe Cassinotto, François Quenet, Fabrizio Panaro, Margaux Hermida, Carole Allimant, Eric Assenat, Georges-Philippe Pageaux, Nicolas Molinari, Boris Guiu

Get full text

Correction: The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner. by Nikola Arsic, Alexandre Ho-Pun-Cheung, Evelyne Lopez-Crapez, Eric Assenat, Marta Jarlier, Christelle Anguille, Manon Colard, Mikaël Pezet, Pierre Roux, Gilles Gadea

Get full text

The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner. by Nikola Arsic, Alexandre Ho-Pun-Cheung, Evelyne Lopez-Crapez, Eric Assenat, Marta Jarlier, Christelle Anguille, Manon Colard, Mikaël Pezet, Pierre Roux, Gilles Gadea

Get full text

Fibroblast growth factor 19 stimulates water intake by José Ursic-Bedoya, Carine Chavey, Guillaume Desandré, Lucy Meunier, Anne-Marie Dupuy, Iria Gonzalez-Dopeso Reyes, Thierry Tordjmann, Eric Assénat, Urszula Hibner, Damien Gregoire

Get full text

Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation by Margaux Hermida, Ancelin Preel, Eric Assenat, Lauranne Piron, Christophe Cassinotto, José Ursic‐Bedoya, Chloé Guillot, Astrid Herrero, Fabrizio Panaro, Georges‐Philippe Pageaux, Boris Guiu

Get full text

Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN... by Thibault Mazard, Caroline Mollevi, Evelyne M. Loyer, Julie Léger, Romain Chautard, Olivier Bouché, Christophe Borg, Paul Armand-Dujardin, Aurore Bleuzen, Eric Assenat, Thierry Lecomte

Get full text

Quantification of HER expression and dimerization in patients' tumor samples using time-resolved Förster resonance energy transfer. by Alexandre Ho-Pun-Cheung, Hervé Bazin, Nadège Gaborit, Christel Larbouret, Patrick Garnero, Eric Assenat, Florence Castan, Caroline Bascoul-Mollevi, Jeanne Ramos, Marc Ychou, André Pèlegrin, Gérard Mathis, Evelyne Lopez-Crapez

Get full text

Non‐transplantable recurrence after percutaneous thermal ablation of ≤3‐cm HCC: Predictors and implications for treatment allocation by Cecilia Gozzo, Margaux Hermida, Astrid Herrero, Fabrizio Panaro, Christophe Cassinotto, Azhar Meerun Mohamad, Eric Assenat, Chloé Guillot, Carole Allimant, Valentina Schembri, Antonio Basile, Sébastien Dharancy, José Ursic‐Bedoya, Boris Guiu

Get full text

GOLT1B Activation in Hepatitis C Virus-Infected Hepatocytes Links ER Trafficking and Viral Replication by Jacqueline Butterworth, Damien Gregoire, Marion Peter, Armando Andres Roca Suarez, Guillaume Desandré, Yannick Simonin, Alessia Virzì, Amal Zine El Aabidine, Marine Guivarch, Jean-Christophe Andrau, Edouard Bertrand, Eric Assenat, Joachim Lupberger, Urszula Hibner

Get full text

A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma by Armando Santoro, Eric Assenat, Thomas Yau, Jean-Pierre Delord, Michela Maur, Jennifer Knox, Stephane Cattan, Kyung-Hun Lee, Gianluca Del Conte, Christoph Springfeld, Elisa Leo, Alexandros Xyrafas, Lauren Fairchild, Feby Mardjuadi, Stephen L. Chan

Get full text

Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study by Morgan Michalet, Karl Bordeau, Marie Cantaloube, Simon Valdenaire, Pierre Debuire, Sebastien Simeon, Fabienne Portales, Roxana Draghici, Marc Ychou, Eric Assenat, Marie Dupuy, Sophie Gourgou, Pierre-Emmanuel Colombo, Sebastien Carrere, François-Regis Souche, Norbert Aillères, Pascal Fenoglietto, David Azria, Olivier Riou

Get full text

A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort by Cindy Canivet, Sophie Gourgou-Bourgade, Bertrand Napoléon, Laurent Palazzo, Nicolas Flori, Pierre Guibert, Guillaume Piessen, Dominique Farges-Bancel, Jean-François Seitz, Eric Assenat, Véronique Vendrely, Stéphanie Truant, Geoffroy Vanbiervliet, Philippe Berthelémy, Stéphane Garcia, Anne Gomez-Brouchet, Louis Buscail, Barbara Bournet, The BACAP Consortium

Get full text

Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort by Lina Hountondji, Christophe Ferreira De Matos, Fanny Lebossé, Xavier Quantin, Candice Lesage, Pascale Palassin, Valérian Rivet, Stéphanie Faure, Georges-Philippe Pageaux, Éric Assenat, Laurent Alric, Amel Zahhaf, Dominique Larrey, Philine Witkowski Durand Viel, Benjamin Riviere, Selves Janick, Stéphane Dalle, Alexandre Thibault Jacques Maria, Thibaut Comont, Lucy Meunier

Get full text

The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients by Benoit You, Frédéric Mercier, Eric Assenat, Carole Langlois-Jacques, Olivier Glehen, Julien Soulé, Léa Payen, Vahan Kepenekian, Marie Dupuy, Fanny Belouin, Eric Morency, Véronique Saywell, Maud Flacelière, Philippe Elies, Pierre Liaud, Thibault Mazard, Delphine Maucort-Boulch, Winston Tan, Bérengère Vire, Laurent Villeneuve, Marc Ychou, Manish Kohli, Dominique Joubert, Alexandre Prieur

Get full text

Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomi... by Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto, Dimitri Pureur, François Ghiringhelli, Eric Assenat, Pascal Hammel, Olivier Rosmorduc, Morgane Stouvenot, Manon Allaire, Mohamed Bouattour, Hélène Regnault, Serge Fratte, Eric Raymond, Emilie Soularue, Stéphanie Husson-Wetzel, Vincent Di Martino, Allison Muller, Anne-Laure Clairet, Christine Fagnoni-Legat, Olivier Adotevi, Aurélia Meurisse, Dewi Vernerey, Christophe Borg

Get full text

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2 by Masatoshi Kudo, Peter R. Galle, Giovanni Brandi, Yoon-Koo Kang, Chia-Jui Yen, Richard S. Finn, Josep M. Llovet, Eric Assenat, Philippe Merle, Stephen L. Chan, Daniel H. Palmer, Masafumi Ikeda, Tatsuya Yamashita, Arndt Vogel, Yi-Hsiang Huang, Paolo B. Abada, Reigetsu Yoshikawa, Kenta Shinozaki, Chunxiao Wang, Ryan C. Widau, Andrew X. Zhu

Get full text